Regulatory

PPAR in Parkinson's Disease-Regulatory

We asked the participants: 

PROTOCOL CHALLENGE 1.1 – REGULATORY STRATEGY

I believe that pioglitazone can be developed for Parkinson's Disease using the 505(b)2 path.

Yes or No?

 

PPAR in Parkinson's Disease - Regulatory Forums

Welcome to the TLS Forum

The forum is the space where TLS users get to comment on the protocol design process. Feel free to draw attention to certain aspects of the Protocol Builder or what you've noticed in the Protocol Builder results. And of course, you can talk to each other!

You're currently viewing posts in the Regulatory section of the PPAR in Parkinson's Disease forum. To see posts, use the drop down menu below. To view other forum sections, please return to the PPAR in Parkinson's Disease page to navigate.

Login or Register to add comments...
Subscribe to RSS - Regulatory